Primary hyperparathyroidism presenting as severe hypercalcemia with acute pancreatitis in pregnancy

References

• MacKenzie-Feder J, Sirrs S, Anderson D, et al. Primary hyperparathyroidism: an overview. Int J Endocrinol. 2011;2011:251410.
   PubMedGoogle Scholar
• Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993–2001: an update on the changing epidemiology of the disease. J Bone Miner Res. 2005;21(1):171–177.
   PubMed Web of Science ®Google Scholar
• Hirsch D, Kopel V, Nadler V, et al. Pregnancy outcomes in women with primary hyperparathyroidism. J Clin Endocrinol Metab. 2015;100(5):2115–2122.
   PubMed Web of Science ®Google Scholar
• DiMarco A, Christakis I, Constantinides V, et al. Undiagnosed primary hyperparathyroidism and recurrent miscarriage: the first prospective pilot study. World J Surg. 2018;42(3):639–645.
   PubMed Web of Science ®Google Scholar
• Vera L, Oddo S, Di Iorgi N, et al. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature. J Med Case Rep. 2016;10(1):361.
   PubMedGoogle Scholar
• Horjus C, Groot I, Telting D, et al. Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol & Metab. 2009;22(8):741–749.
   PubMed Web of Science ®Google Scholar
• Nadarasa K, Bailey M, Chahal H, et al. The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2014;2014:140056.
   PubMedGoogle Scholar
• Peacock M, Bilezikian JP, Klassen PS, et al. Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. J Clin Endocrinol Metab. 2005;90(1):135–141.
   PubMed Web of Science ®Google Scholar
• Fraser WD. Hyperparathyroidism. Lancet. 2009;374(9684):145–158.
   PubMed Web of Science ®Google Scholar
• Herrera-Martínez AD, Bahamondes-Opazo R, Palomares-Ortega R, et al. Primary hyperparathyroidism in pregnancy: a two-case report and literature review. Case Rep Obstet Gynecol. 2015;2015:171828.
   PubMedGoogle Scholar
• Amaya García MJ, Acosta Feria M, Soto Moreno A, et al. Primary hyperparathyroidism in pregnancy. Gynecol Endocrinol. 2004;19(2):111–114.
   PubMed Web of Science ®Google Scholar
• McMullen TPW, Learoyd DL, Williams DC, et al. Hyperparathyroidism in pregnancy: options for localization and surgical therapy. World J Surg. 2010;34 (8):1811–1816.
   PubMed Web of Science ®Google Scholar
• Norman AJ, Politz D, Politz L. Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin Endocrinol (Oxf). 2009;71(1):104–109.
   PubMed Web of Science ®Google Scholar
• Sunkara T, Caughey ME, Rawla P, et al. Severe acute pancreatitis as an index clinical manifestation of parathyroid adenoma. Cureus. 2018;10(4):e2445.
   PubMed Web of Science ®Google Scholar
• Som M, Stroup JS. Primary hyperparathyroidism and pregnancy. Proc (Bayl Univ Med Cent). 2011;24(3):220–223.
   PubMedGoogle Scholar
• Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv. 2002;57(6):365–376.
   PubMed Web of Science ®Google Scholar
• Felger EA, Kandil E. Primary hyperparathyroidism. Otolaryngol Clin North Am. 2010;43(2):417–432.
   PubMed Web of Science ®Google Scholar
• Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med. 2000;343(25):1863–1875.
   PubMed Web of Science ®Google Scholar
• Vitetta GM, Neri P, Chiecchio A, et al. Role of ultrasonography in the management of patients with primary hyperparathyroidism: retrospective comparison with technetium-99m sestamibi scintigraphy. J Ultrasound. 2014;17(1):1–12.
   PubMedGoogle Scholar
• Dochez V, Ducarme G. Primary hyperparathyroidism during pregnancy. Arch Gynecol Obstet. 2015;291(2):259–263.
   PubMed Web of Science ®Google Scholar
• DiMarco AN, Meeran K, Christakis I, et al. Seventeen cases of primary hyperparathyroidism in pregnancy: a call for management guidelines. J Endocr Soc. 2019;3 (5):1009–1021.
   PubMed Web of Science ®Google Scholar
• Goodman S. Anesthesia for nonobstetric surgery in the pregnant patient. Semin Perinatol. 2002;26(2):136–145.
   PubMed Web of Science ®Google Scholar
• Stathopoulos IP, Liakou CG, Katsalira A, et al. The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones (Athens). 2011;10(4):280–291.
   PubMedGoogle Scholar
• Major P, Lortholary A, Hon J, et al. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J Clin Oncol. 2001;19(2):558.
   PubMed Web of Science ®Google Scholar
• Green SB, Pappas AL. Effects of maternal bisphosphonate use on fetal and neonatal outcomes. Am J Health Syst Pharm. 2014;71(23):2029–2036.
   PubMed Web of Science ®Google Scholar
• Phitayakorn R, McHenry CR. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg. 2008;206(6):1106–1115.
   PubMed Web of Science ®Google Scholar
• Moreno-Fernández J, Molina-Pueras MJ, Calañas-Continente A, et al. Pancreatitis por hiperparatiroidismo primario durante el embarazo [Pancreatitis and primary hyperparathyroidism during pregnancy]. Endocrinol Nutr. 2006;53(1):56–59. Spanish.
   Google Scholar
• Cicci JD, Buie L, Bates J, et al. Denosumab for the management of hypercalcemia of malignancy in patients with multiple myeloma and renal dysfunction. Clin Lymphoma Myeloma Leuk. 2014;14(6):e207.
   PubMedGoogle Scholar
• Okamatsu N, Sakai N, Karakawa A, et al. Biological effects of anti-RANKL antibody administration in pregnant mice and their newborns. Biochem Biophys Res Commun. 2017;491(3):614–621.
   PubMed Web of Science ®Google Scholar
• Boyce RW, Varela A, Chouinard L, et al. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Bone. 2014;64:314–325.
   PubMed Web of Science ®Google Scholar